ArticleJournal of neuro-oncology2024

Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells.

Simon Zeuner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.